CDSCO to go online for all services in six months
The Central Drugs Standard Control
Organisation (CDSCO) is set to become paperless within six months with
completely shifting its services to online portal Sugam. The agency digitized
60-70 per cent of its services through Sugam portal so far.
In another six months we are planning to go
completely electronic for all our services by doing away with requirement of
any physical documents, said a senior CDSCO official.
With the launch of Sugam on November 14,
2015, firms can apply online for grant of registration certificates for import
of drugs or import license of drugs in Form 10, under D&C Rules. They can
also file online applications with respect to import registration and license
of medical devices. Online submission has also been started for grant of
approval to conduct bioequivalence studies for
export purposes.
CDSCO has recently started process for online
submission for clinical trial approval for Biologicals (Vaccines) on Sugam.
Firms can request to test vaccine samples at CDL Kasauli and receive batch
release certificate online. Firms can add their license details issued by State
FDA's on Sugam. They can submit online application for grant of approval for
import and manufacture of new vaccine, registration and import license for
vaccines, conducting clinical trial.
The agency is in process of starting online
submission for clinical trial approval of new chemical entity. Over next three
months, it will start online submission for FDC approval, grant of Certificate
of Pharmaceutical Product to WHO GMP certified manufacturing units where
inspections have been conducted, he informed.
Besides this, we have integrated all seven
laboratories of CDSCO with Sugam and data related to samples of drugs tested in
these laboratories will be uploaded on the portal from next month which will
enable us to immediately alert the state drug controllers if poor drug quality
is detected. It will eventually facilitate drug recall in a timely manner, he
opined.
We have also developed database of drug
retailers and wholesalers from ten states including Maharashtra, Goa, Gujarat,
Puducherry, Delhi, Jharkhand which will soon be published on CDSCO
website. The database proves to be effective in pan India drug recall, he
stated.
Some states have started online process for
grant of drug distribution and manufacturing licences. These portals are
affiliated to CDSCO enabling it to get access to all the data generated through
the system.
Apart from drug traders’ database, the agency
is set to put in place a single platform containing data pertaining to
manufacturing facilities in the country in a month. Efforts are being made to
get states onboard so that software is provided to manufacturers who put their
plants’ data in the software, said the official.
Recently the ministry of health and family
welfare has notified Medical devices rules. The new rules will go into effect
January 1, 2018. An authorised agent having licence to manufacture for sale or
distribution or wholesale licence for sale or distribution under these rules,
intending to import medical devices, will be required to make an application
for grant of import licence for medical device to the Central Licensing
Authority through an identified online portal of the ministry. The services of
Sugam will be extended to application with respect to grant of import licence
for medical device.
The agency will soon start online submission
of drug samples by its drug inspectors for lab testing. The sample analysis
report will be put online by the respective CDSCO laboratory. It will lead to
reduction in time required in submitting the hard copy to the respective lab by
drug inspectors and fast track the drug testing process. The initiative is a
part of slew of measures initiated by CDSCO to make its services online, he said.
The main aim of this e-governance drive is to
bring in transparency, accountability and competency in CDSCO which allows
creating a real time platform and improve the safety and security programmes
taken up by it.
Comments
Post a Comment